8-K: Ingersoll Rand Reports Strong Q3 2025 Results

Ingersoll Rand Inc. announced strong financial results for the third quarter of 2025, driven by robust orders and revenue growth across both segments.

Summary

• Orders increased by 8% to $1,942 million compared to the third quarter of 2024.
• Revenues grew by 5% to $1,955 million compared to the third quarter of 2024.
• Net income attributable to Ingersoll Rand Inc. was $244 million, or $0.61 per diluted share.
• Adjusted net income reached $346 million, resulting in $0.86 per adjusted diluted share.
• Adjusted EBITDA was $545 million, up 2% year-over-year, with a margin of 27.9%.
• Operating cash flow generated $355 million, and free cash flow was $326 million.
• Liquidity stood at $3.8 billion as of September 30, 2025, comprising $1.2 billion in cash and $2.6 billion in undrawn credit facilities.
• The Industrial Technologies and Services (IT&S) segment reported orders up 7% (0.3% organic) and revenues up 5% (down 2% organic), with Segment Adjusted EBITDA down 1% to $448 million and a margin of 29.0%.
• The Precision and Science Technologies (P&ST) segment saw orders increase by 11% (7% organic) and revenues by 5% (2% organic), with Segment Adjusted EBITDA up 8% to $128 million and a margin of 30.8%.
• Full-year 2025 guidance for Adjusted EBITDA was revised to $2,060 million $2,090 million (+2% to +4% YoY) and Adjusted EPS to $3.25 $3.31 (-1% to +1% YoY).

Sentiment

Score: 7

Explanation: Ingersoll Rand reported strong overall financial results for Q3 2025, with robust orders and revenue growth, healthy Adjusted EBITDA, and significant liquidity. The Precision and Science Technologies segment showed particularly strong organic growth. However, the Industrial Technologies and Services segment experienced an organic revenue decline, and the full-year Adjusted EPS guidance was adjusted to a flat to slightly negative range, tempering the overall positive sentiment.

Positives

• Strong overall orders growth of 8% to $1,942 million, indicating robust demand.
• Solid revenue growth of 5% to $1,955 million, demonstrating market penetration.
• Adjusted EBITDA increased by 2% to $545 million, reflecting continued profitability.
• The Precision and Science Technologies (P&ST) segment delivered strong organic orders growth of 7% and organic revenue growth of 2%, with an 8% increase in Adjusted EBITDA and an 80 basis point margin improvement year over year.
• The Industrial Technologies and Services (IT&S) segment achieved its third consecutive quarter of positive organic orders growth (0.3%).
• Maintained a strong financial position with $3.8 billion in liquidity, including $1.2 billion in cash on hand.
• Successfully deployed $249 million to M&A in the quarter, including the acquisition of Dave Barry Plastics.
• Returned $201 million to shareholders through $193 million in share repurchases and $8 million in quarterly dividend payments.

Negatives

• Organic revenue for the Industrial Technologies and Services (IT&S) segment declined by 2%.
• IT&S Segment Adjusted EBITDA decreased by 1% to $448 million, with its margin down 170 basis points, attributed to organic volume declines, tariff impacts, and commercial investments.
• Free cash flow for the quarter decreased to $326 million from $374 million in the prior year period, although year-to-date free cash flow remained approximately flat.
• Net debt-to-Adjusted EBITDA leverage increased by 0.1x to 1.8x compared to the prior year.
• The revised full-year 2025 Adjusted EPS guidance range of $3.25 $3.31 represents a potential year-over-year change of -1% to +1%, indicating a flat to slight decline at the lower end.

Risks

• Adverse impact on operations and financial performance due to geopolitical tensions, natural disaster, catastrophe, global pandemics, cyber events, or other events outside of control.
• Unexpected costs, charges or expenses resulting from completed and proposed business combinations.
• Uncertainty of the expected financial performance of the Company.
• Failure to realize the anticipated benefits of completed and proposed business combinations.
• Inability of the Company to implement its business strategy.
• Difficulties and delays in achieving revenue and cost synergies.
• Inability of the Company to retain and hire key personnel.
• Evolving legal, regulatory and tax regimes.
• Changes in general economic and/or industry specific conditions.
• Actions by third parties, including government agencies.
• Other risk factors detailed in Ingersoll Rand's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission.

Future Outlook

Ingersoll Rand is adjusting its full-year 2025 guidance, expecting total revenue growth of 4-6% (organic (2)-0%), Adjusted EBITDA between $2,060 million and $2,090 million (+2% to +4% YoY), and Adjusted EPS between $3.25 and $3.31 (-1% to +1% YoY). The company anticipates continued resilience and durable long-term growth through its agile business model and operational excellence.

Management Comments

• "We delivered positive organic orders growth in the third quarter across both segments. Our performance demonstrates the resilience of our business, which combined with our strong balance sheet, enables durable long-term growth. We remain well positioned for future growth with our proven agile business model, operational excellence, and ownership mindset." Vicente Reynal, chairman and chief executive officer.

Industry Context

The company's strong performance in mission-critical flow creation, life science, and industrial solutions suggests a robust demand environment for specialized industrial equipment and technologies. The focus on "Ingersoll Rand Execution Excellence (IRX)" and an "agile business model" indicates a strategy to outperform in a competitive industrial landscape, leveraging operational efficiency and strategic M&A. The organic orders growth in both segments, particularly in Precision and Science Technologies, suggests strength in high-value, specialized markets, while the organic revenue decline in IT&S points to some challenges in broader industrial markets or specific product lines.

Comparison to Industry Standards

• The Adjusted EBITDA margin of 27.9% is strong for an industrial manufacturer, indicating efficient operations and pricing power, potentially outperforming many general industrial peers.
• The net debt-to-Adjusted EBITDA leverage of 1.8x is a healthy level, suggesting a conservative balance sheet compared to highly leveraged industrial conglomerates or private equity-backed firms.
• The consistent capital allocation strategy, including M&A and shareholder returns, aligns with best practices for mature industrial companies seeking growth and shareholder value.
• Organic orders growth in both segments, especially 7% in P&ST, indicates strong market penetration and product relevance, potentially exceeding the average growth rates of some slower-growing industrial sectors.
• The decline in IT&S organic revenue, however, might lag behind some more dynamic industrial sub-sectors or competitors with stronger exposure to booming end-markets.

Stakeholder Impact

• Shareholders: Positive impact from strong overall financial performance, share repurchases ($193 million), and quarterly dividend payments ($8 million). Potential for long-term value creation through strategic M&A and a resilient business model.
• Customers: Benefit from the company's focus on "mission-critical flow creation and life science and industrial solutions" and "exceptional performance and durability."
• Employees: The company is "dedicated to Making Life Better for our employees," implying a focus on employee well-being and development.
• Acquired Businesses (e.g., Dave Barry Plastics): Integration into Ingersoll Rand's portfolio, potentially benefiting from broader resources and market reach.

Next Steps

• Host a live earnings conference call on October 31, 2025, at 8:00 a.m. (Eastern Time) to discuss the third quarter results.
• Continue to implement its comprehensive capital allocation strategy, including M&A and shareholder returns.
• Focus on durable long-term growth through its agile business model and operational excellence.

Key Dates

Recommendation

While Ingersoll Rand demonstrated strong overall orders and revenue growth, and the P&ST segment performed exceptionally well, the organic revenue decline in the larger IT&S segment and the flat to slightly negative revised full-year Adjusted EPS guidance suggest some headwinds. The company's strong liquidity and capital allocation strategy are positives, but the mixed operational performance warrants a "hold" recommendation, advising investors to monitor future organic growth trends and margin performance, especially in the IT&S segment, before making further investment decisions.

Keywords

Ingersoll Rand, IR, Q3 2025, Financial Results, Earnings, Industrial Technologies, Precision and Science Technologies, Adjusted EBITDA, Free Cash Flow, Orders Growth, Revenue Growth, M&A, Share Repurchase, Dividend, SEC Filing, 8-K